Keyphrases
Alzheimer's Disease
100%
Alzheimer's Disease Pathology
16%
Amyloid Imaging
8%
Brain Volume
8%
Cerebrospinal Fluid
58%
Cerebrospinal Fluid Biomarkers
8%
Cognitive Assessment
8%
Cognitive Decline
8%
Cognitive Impairment
33%
Cognitively Normal
50%
Dementia
16%
Diagnostic Biomarker
100%
Diagnostic Marker
8%
Diagnostic Utility
8%
Disease-modifying Therapy
8%
Early Alzheimer's Disease
16%
Early Signs
8%
Fluid Level
8%
Neuronal Injury
8%
Neuronal Loss
8%
Phosphorylated tau181
25%
Pittsburgh Compound B
8%
Prognostic Biomarker
100%
Prognostic Marker
8%
Structural Magnetic Resonance Imaging (sMRI)
8%
Success Probability
8%
Tau Amyloid
16%
Visinin-like protein-1
100%
Medicine and Dentistry
Alzheimer's Disease
100%
Amyloid Protein
75%
Biological Marker
100%
Cerebrospinal Fluid
66%
Cognitive Assessment
8%
Cognitive Defect
33%
Diagnosis
100%
Disease Modifying Therapy
8%
Pittsburgh Compound B
8%
Structural Magnetic Resonance Imaging
8%
Synapsin I
100%
Tau
41%
Visinin
100%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
75%
Cognitive Disorders
33%
Structural Magnetic Resonance Imaging
8%
Synapsin I
100%
Visinin
100%
Biochemistry, Genetics and Molecular Biology
Amyloid Protein
75%
Brain Size
8%
Cerebrospinal Fluid Level
8%
Liquid
58%
Pittsburgh Compound B
8%
Structural Magnetic Resonance Imaging
8%
Synapsin I
100%
Tau
41%